CIBC raised the firm’s price target on Nutrien (NTR) to $66 from $64 and keeps an Outperformer rating on the shares. The firm cites increased ...

CIBC analyst Hamir Patel reiterated a Buy rating on CCL Industries (CCDBF – Research Report) today and set a price target of C$96.00. The ...

CIBC Asset Management Inc lifted its stake in Globus Medical, Inc. (NYSE:GMED – Free Report) by 5.3% in the fourth quarter, ...

CIBC Asset Management Inc increased its stake in shares of Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 5.3% in the ...

The stock has been on fire since late last year, but CIBC analyst Todd Coupland thinks there is still money to be made on ...

"CLUE," the hilarious murder mystery comedy inspired by the Hasbro board game and adapted from the fan-favorite film, is ...

Clue, or Cluedo in the country of its birth, is one of the best board games of all time. Colonel Mustard, Mrs. Peacock and ...

Royal Bank of Canada ( TSX:RY) and Canadian Imperial Bank of Commerce ( TSX:RY) are two of Canada’s largest financial ...

As previously reported, CIBC upgraded Capital Power (CPXWF) to Outperformer from Neutral with a price target of C$64, down ...

CIBC (TSX:CM) stock looks like a great bargain for 2025 and beyond. The post Outlook for CIBC Stock in 2025 appeared first on ...

Fintel reports that on February 18, 2025, CIBC upgraded their outlook for TransAlta (NYSE:TAC) from Neutral to Outperformer.

As previously reported, CIBC upgraded TransAlta (TAC) to Outperformer from Neutral with a price target of C$19.50, down from ...